Metamizol Teva-Ratiopharm

Metamizole, the active ingredient in Metamizol Teva-Ratiopharm, is a pyrazolone analgesic presented as an oral formulation for systemic use. It provides analgesic and antipyretic effects for the treatment of pain and fever in adults.

GNH USA supplies Metamizol Teva-Ratiopharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizol Teva-Ratiopharm acts as an analgesic and antipyretic within the pyrazolone drug class.

- Pain: reduces moderate to severe acute and chronic pain. - Fever: lowers elevated body temperature associated with infection or inflammation. - Visceral pain: alleviates pain originating from internal organs. - Postoperative pain: manages pain following surgical procedures.

Metamizole may cause a range of adverse reactions.

Common Side Effects: - Nausea - Dizziness - Hypotension - Rash or mild skin irritation - Headache - Vomiting

Serious or Rare Side Effects: - Agranulocytosis (severe reduction in white blood cells) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic shock - Severe liver injury - Acute kidney failure - Other serious blood dyscrasias

Before prescribing Metamizol Teva-Ratiopharm, clinicians should consider several safety measures.

- Assess renal function: adjust use in severe renal impairment. - Monitor blood counts: risk of agranulocytosis requires periodic hematologic testing. - Avoid in known hypersensitivity: discontinue immediately if allergic reaction occurs. - Use caution in hepatic disease: monitor liver enzymes during therapy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Metamizol Teva-Ratiopharm can interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Concurrent use with other myelosuppressive agents: increased risk of bone marrow suppression. - Combination with other NSAIDs or COX inhibitors: heightened gastrointestinal toxicity. - Co-administration with anticoagulants: potential for enhanced bleeding.

Moderate Interactions (Monitor Closely): - Interaction with ACE inhibitors: may potentiate hypotensive effect. - Use with diuretics: monitor electrolytes and renal function. - Concurrent use with carbamazepine: may reduce analgesic efficacy.